AI-generated summary
In this randomized controlled trial, the authors compared chlorhexidine gel, photobiomodulation with a 980 nm diode laser, and oral nanocurcumin for gingivitis in 60 visually impaired children. The authors report that all three groups showed significant reductions in plaque and gingival indices, with nanocurcumin showing the largest decreases. The abstract describes the work as a comparative study with a small sample of children.
- Participants
- 60
- Who or what was studied
- Visually impaired children aged 8-14 years with mild to moderate gingivitis
- Wavelengths
- 980 nm
- Limits stated in the abstract
- The abstract reports a single trial of 60 children split into three groups of 20, with no long-term follow-up described beyond Day 21.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 980 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Randomized controlled trial, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.